Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Intranasal vs Intravenous Dexamethasone
NCT05647408Phase 1Completed
- Sponsor
- Universidad Nacional Autónoma de México
- Start
- Nov 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexamethasone in inflammation (2 arms), sponsored by Universidad Nacional Autónoma de México. Primary endpoint: Absolute Bioavailability of Dexamethasone at 2 weeks. Started Nov 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT05647408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647408.